NEXGEL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
NEXGEL, INC. (NXGL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-17
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-17 | |||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-17 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-31 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-27 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-04-10 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-28 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 0.00% 10-K · filed 2021-03-31 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 0.00% 10-K/A · filed 2020-04-03 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2020-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |